Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HLA Antibodies”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Post-approval studies (Phase 4)Study completedNCT02078193
What this trial is testing

Efficacy of Belatacept in Reducing DSA

Who this might be right for
Kidney Transplantation
East Carolina University 3
Post-approval studies (Phase 4)UnknownNCT02208791
What this trial is testing

Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Sao Paulo General Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00003868
What this trial is testing

Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Not applicableNot Yet RecruitingNCT06774365
What this trial is testing

CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation

Who this might be right for
Heart TransplantationRejection Heart TransplantHLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna 683
Not applicableUnknownNCT05282875
What this trial is testing

Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

Who this might be right for
Kidney TransplantationImmunosuppressive AgentsHLA Sensitization+1 more
Central Hospital, Nancy, France 430
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Not applicableUnknownNCT02556879
What this trial is testing

Immunization Anti HLA in the Liver Transplant Recipients (DSATH)

Who this might be right for
Liver TransplantationGraft Failure
Assistance Publique - Hôpitaux de Paris 100
Not applicableLooking for participantsNCT04239703
What this trial is testing

Trifecta-Kidney cfDNA-MMDx Study

Who this might be right for
Kidney Transplant Rejection
University of Alberta 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT00002554
What this trial is testing

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT01502267
What this trial is testing

Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

Who this might be right for
End Stage Renal Disease
Seoul National University Hospital 2
Not applicableStudy completedNCT00460122
What this trial is testing

Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients

Who this might be right for
HealthyTransfusion Reactions
National Institutes of Health Clinical Center (CC) 135
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableStudy completedNCT03798860
What this trial is testing

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Who this might be right for
Lung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
Hannover Medical School 340
Not applicableStudy completedNCT03238443
What this trial is testing

Interest of the Donor-specific Antibodies After Liver Transplantation

Who this might be right for
Liver Transplant
University Hospital, Lille 120
Not applicableActive Not RecruitingNCT05184426
What this trial is testing

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

Who this might be right for
Transplant FailureHeart Transplant RejectionAntibody-mediated Rejection
Juan Francisco Delgado Jimenez 90
Testing effectiveness (Phase 2)Looking for participantsNCT06362967
What this trial is testing

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

Who this might be right for
High Titers of Anti-HLA Antibody (MFI ≥5000)
Anhui Provincial Hospital 30
Load More Results